Compare FMC Corp (FMC) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? FMC Corp trades at $11.29 (market cap $1.36B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.83. The key difference: FMC Corp pays a 2.95% dividend while YieldMax Magnificent 7 Fund of Option Income ETFs pays none, and YieldMax Magnificent 7 Fund of Option Income ETFs is trading nearer its 52-week high, FMC Corp nearer its low. Which is the better fit depends on your goals.
| FMC | YMAG | |
|---|---|---|
Market Cap | $1.36B | — |
Sector | Basic Materials | Income / Options Overlay |
52-Week High | $43.90 | $15.98 |
52-Week Low | $10.72 | $11.00 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
YMAG trades at $11.86, up 0.59% today, with technicals showing a bullish trend but oscillators indicating potential overbought conditions. The ETF maintains a consistent weekly dividend distribution strategy, with recent payouts ranging from $0.07 to $0.40 per share. Recent news highlights its structure as a fund of option income ETFs targeting the Magnificent Seven stocks, designed to monetize volatility while offering income.
The outlook for YMAG hinges on its ability to generate sustainable yields through covered calls amid market volatility. Key risks include NAV decay from the options strategy and underperformance in strong bull markets. Analyst sentiment is mixed, with some viewing it as a tactical buy for income-focused investors in rangebound markets, while others caution about limited upside potential compared to direct equity exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
